Canadian marijuana producer Tilray is lowering the value of its U.S. CBD assets, citing delays from health regulators. Tilray executives reported a $112 million writedown of the value of its 2019 agreement with Authentic Brands Group. The two companies planned to bring CBD products to mass retail outlets, but the lack of direction from the […]